Partnership with Tata Memorial Centre
Posted on 19/11/2012
Prof Rajendra Badwe and Prof Arnie Purushotham.
King’s College London signed a Memorandum of Understanding (MOU) with the Tata Memorial Centre (TMC), Mumbai, on 19 November 2012. The MOU marks the launch of a formal partnership between TMC and King’s Health Partners Integrated Cancer Centre – one of the world’s leading academic centres that combines first class clinical care with groundbreaking research into personalised cancer treatment. Delivering affordable cancer care for an ageing global population is one of the main challenges the collaboration will address.
The partnership with TMC also signals King’s renewed commitment to developing partnerships in India in areas that the College has particular expertise – with cancer at the forefront in the medical sciences, along with neuroscience and mental health. Engagement with India forms a core part of the College’s international strategy – to develop links for research collaboration and encourage the mobility of staff and students.
King’s recently sent a large academic delegation to Mumbai and Delhi, headed by Principal Professor Sir Rick Trainor, to engage with partner organisations and pursue research opportunities in order to accelerate potential impact and beneficial outcomes for society.
The agreement between King’s and TMC will allow the two centres to pursue joint research and development opportunities and exchange of staff and students. The institutions will focus on training fellowships; exchange visits; cancers of the breast, lung, head and neck; clinical trials; cancer policy, economics, epidemiology and public health programmes.
King’s is already a world leader for research into cancer. King’s Health Partners Integrated Cancer Centre has rapidly become a pioneer in a new kind of combined care and research model that promises to accelerate the development of cancer treatments. The Centre is a unique collaboration between the institutions that comprise King’s Health Partners; namely, the hospitals that are linked to King’s College London (Guy’s and St Thomas’, King’s College and the South London and Maudsley Hospital) and the academic research teams in the university itself.
New technology and advances in genetics and personalised medicine are offering unprecedented targeted therapeutic opportunities for breast, prostate, lung cancer and haemato-oncology (blood diseases). The Centre is now looking to build on its position in all these areas by collaborations worldwide with leading international partners. Research teams at King’s are also keen to collaborate to find ways of more affordable cancer care, as an ageing global population and expensive new drugs and technologies are starting to place a great financial burden on society.
Largest cancer centre in India
The TMC is the oldest and largest cancer centre in India. It is the leader in the provision of cancer care and training human resource for the country and has recently spearheaded a movement to create a network of cancer centres under the “National Cancer Grid” in India.
TMC has been at the forefront of cutting-edge cancer research in India, with several large randomised trials in head and neck, breast, oesophageal and cervical cancers now underway and expected to answer burning clinical questions in these cancers.
Professor Arnie Purushotham, Director of King’s Health Partners Integrated Cancer Centre said: ‘I’m delighted to be here in Mumbai to sign this partnership agreement with the Tata Memorial Centre. The TMC is not only a major international cancer centre but is also a leading light in developing cost-effective solutions to tomorrow’s global cancer burden. The approach of TMC and India to tackling cancer against a very different and complex healthcare background has much to offer high income countries which are challenged to deliver affordable cancer care.
‘Bringing together scientists and clinicians from all over the world who are leaders in their field means we will really be able to drive innovation and improve cancer outcomes for our patients.’
Professor Rajendra Badwe, Director, Tata Memorial Centre said: ‘This is an historic moment for both institutions and formalises a relationship which has forged a strong bond within a relatively short period of two years. Both institutions are united by a common vision of improving patient care in both countries and addressing the distinct spectra of cancers in the two countries. It is not incidental that the relative strengths of the two institutions complement the needs of the other and this will be a mutually beneficial relationship.’
Notes to editors
For further information please contact Marianne Slegers, International Press Officer, on email@example.com or +44 207 848 3840.
Photos and interviews available on request.
For further information on King's visit our 'King's in Brief' page.
About King’s Health Partners Integrated Cancer Centre
King’s Health Partners Integrated Cancer Centre is a collaboration between Guy’s and St Thomas’ and King’s College Hospital, the South London and Maudsley NHS Foundation Trusts and King’s College London. It brings together world-class clinical services, research and academic excellence in teaching for the benefit of patients in London and beyond. Working with acute care, academic, general practitioner and community partners as well as the local population, the Cancer Centre is developing and applying innovations in the discovery, development and delivery of new types of cancer care. King’s College London is at the forefront of cutting-edge research, with particular strengths in breast cancer, haemato-oncology, prostate cancer, lung cancer, palliative care, psychological medicine, cell biology, imaging, and epidemiology.
About Tata Memorial Centre
The Tata Memorial Centre (TMC) comprises the Tata Memorial Hospital (TMH) and the Advanced Centre for Training, Research and Education in Cancer (ACTREC). TMC has comprehensive patient care, education, training and clinical research in cancer as its core mandate. Over 30,000 new patients with cancer from all over the country are seen and treated at the hospital every year. The hospital is a comprehensive cancer-care facility with human resource, infrastructure and equipment comparable to the best in the world. With state of the art facilities in surgical, medical and radiation oncology and allied fields, quality care is provided to patients at highly subsidised cost. With over 60% of patients treated free, standardised treatment is offered to all patients regardless of socio-economic status. TMC is firmly committed to the long-term vision of providing uniform standards of affordable medical care to patients from all over the country at their doorsteps and the creation of the National Cancer Grid is a step in that direction.